OpGen
OpGen is a precision medicine company harnessing the power of molecular diagnostics to help combat infectious diseases. They develop highly multiplexed syndromic molecular panels to address antimicrobial resistance (AMR), improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms. Their mission is to optimize the treatment of life-threatening, drug-resistant infections and transform patient care through advanced molecular microbiology.
Industries
Nr. of Employees
medium (51-250)
OpGen
Rockville, Maryland, United States, North America
Products
Multiplex lower respiratory tract infection molecular panel
Syndromic molecular assay for rapid detection of common lower respiratory bacterial pathogens and multiple resistance markers directly from respiratory specimens; designed to shorten time-to-result compared to culture.
Hospital-acquired pneumonia / secondary bacterial pneumonia molecular panel
Molecular panel application intended for detection of bacterial pathogens implicated in hospital-acquired or secondary bacterial pneumonia, including use in COVID-19 patient cohorts.
Multiplex lower respiratory tract infection molecular panel
Syndromic molecular assay for rapid detection of common lower respiratory bacterial pathogens and multiple resistance markers directly from respiratory specimens; designed to shorten time-to-result compared to culture.
Hospital-acquired pneumonia / secondary bacterial pneumonia molecular panel
Molecular panel application intended for detection of bacterial pathogens implicated in hospital-acquired or secondary bacterial pneumonia, including use in COVID-19 patient cohorts.
Services
Clinical performance studies and trial support
Design and conduct of analytical and clinical studies, including multicenter trials and retrospective reviews, to evaluate diagnostic panels and their clinical impact.
Assay control provision and technical documentation
Supply of control materials and datasheets to support laboratory verification and ongoing quality control of molecular respiratory panels.
Customer and technical support
Channels for customer inquiries and technical assistance related to diagnostic products and services.
Clinical performance studies and trial support
Design and conduct of analytical and clinical studies, including multicenter trials and retrospective reviews, to evaluate diagnostic panels and their clinical impact.
Assay control provision and technical documentation
Supply of control materials and datasheets to support laboratory verification and ongoing quality control of molecular respiratory panels.
Customer and technical support
Channels for customer inquiries and technical assistance related to diagnostic products and services.
Expertise Areas
- Infectious disease molecular diagnostics
- Lower respiratory tract infection testing
- Antimicrobial resistance detection
- Clinical performance validation and multicenter trials
Key Technologies
- Multiplex PCR / multiplex nucleic acid amplification
- Syndromic molecular panels
- Resistance gene detection assays
- Culture-independent pathogen detection